JSON
Ribeiro AL, Barton A, Schwenk JM, Bertheussen H, de Wit M, Goodyear C, Siebert S, Pennington SR, FitzGerald O
Rheum Dis Clin North Am 51 (3S2) e1-e15 [2025-08-00; online 2026-03-26]
Predicting treatment response is a key unmet need for people with psoriatic disease. In this article, the importance of personalized medicine is emphasized and molecular biomarker concepts are discussed. The literature related to biomarkers of treatment response in psoriatic disease is reviewed in detail. Finally, the limitations of current candidate biomarkers, emerging biomarkers, and future directions and challenges in biomarker research are highlighted.
PubMed 41997622
DOI 10.1016/j.rdc.2026.02.012
Crossref 10.1016/j.rdc.2026.02.012
pii: S0889-857X(26)00012-8